BPC-157 + TB-500 · two SKUs · research use only
The BPC-157 / TB-500 pairing, and how to source both.
BPC-157 and TB-500 are the two compounds most frequently discussed together in academic tissue- and connective-tissue research literature. They are not a single product — they are two separate peptides studied as a pair. This page covers how the literature pairs them, what Titan stocks, and the discount tiers that apply when you order both.
Why the two are studied together
BPC-157 (Body Protection Compound 157) is cited across angiogenesis, tendon-fibroblast, and GI-mucosa research; TB-500, the Thymosin Beta-4 active fragment, is cited in actin-sequestration and angiogenesis research. The two are paired in protocol literature because they are discussed as acting through complementary mechanisms in tissue models — which is why researchers source them as a set.
TB-500 vs BPC-157 →Two separate SKUs, not one vial
Titan lists the pairing as two independent peptides: a 5mg lyophilized BPC-157 vial and a 5mg lyophilized TB-500 vial. Each is reconstituted with bacteriostatic water before in-vitro use. Keeping them as separate SKUs means each carries its own lot-matched documentation rather than a blended, harder-to-verify product.
Where to buy TB-500 →Documentation on each lot
Because both are research reagents, each ships with a lot-matched release sheet keyed to the code on that specific vial, with an HPLC main-peak purity result against a ≥99% internal target and a mass-spec identity confirmation. You are verifying two units, so confirm the paperwork on each rather than assuming a stack shares one document.
How to read the COA →The multi-item discount math
Ordering both vials together is exactly the case the tiered codes are built for. BULK15 takes 15% off three or more items, TITAN20 takes 20% off orders over $250, and FIRST10 applies 10% to a first order. The two-vial combined list is $144.98 before any code — apply the best-applicable tier at checkout.
Browse the catalog →How checkout settles
Titan is crypto-only — BTC, USDC, or SOL. The network and wallet are shown before payment and an order ID is logged with support first. Paying in USDC holds the combined total at exactly the quoted figure even if BTC moves between cart and confirmation.
Crypto checkout walkthrough →Where the research-use line sits
Both compounds are research reagents, not medicines. Nothing on this page is dosing guidance or a human-use protocol — it describes how the two are discussed in published research and how to source documented material. Neither is approved for human use.
See the testing workflow →The detail, in plain terms
Two documented vials, one research pairing.
A 'stack' in the research-reagent market means two compounds sourced together, not a blended product. Titan keeps them separate so each lot is independently verifiable, and structures the discount tiers around multi-item orders.
- BPC-157
- 5mg lyophilized vial, $54.99 — SC research format.
- TB-500
- 5mg lyophilized vial, $89.99 — Thymosin Beta-4 active fragment.
- Combined list
- $144.98 before any discount code.
- Best tiers
- BULK15 −15% (3+ items) · TITAN20 −20% over $250 · FIRST10 −10% first order.
- COA path
- A separate lot-matched release sheet for each vial, on request.
- Checkout
- Crypto-only — BTC, USDC, SOL; on-chain confirm before dispatch.
Questions researchers ask
Before you order.
- Is the BPC-157 + TB-500 stack one product?
- No. It is two separate peptides — a 5mg BPC-157 vial and a 5mg TB-500 vial — that are frequently studied together in tissue-research literature. Titan keeps them as independent SKUs so each carries its own lot-matched documentation. They are sold strictly for in-vitro laboratory research, not for human use.
- How much does the BPC-157 + TB-500 pairing cost?
- The 5mg BPC-157 vial is $54.99 and the 5mg TB-500 vial is $89.99, a combined list of $144.98 before any code. BULK15 (15% off three or more items), TITAN20 (20% off over $250), or FIRST10 (10% off a first order) apply at checkout; the displayed total is what the crypto payment settles at.
- Why are BPC-157 and TB-500 studied together?
- In academic protocol literature the two are discussed as acting through complementary mechanisms in tissue and connective-tissue research — BPC-157 across angiogenesis and GI-mucosa work, TB-500 across actin-sequestration and angiogenesis work. That is why researchers commonly source them as a set. Titan makes no human-use or efficacy claims.
- Does each compound come with its own COA?
- Yes — because they are separate SKUs, each ships with its own lot-matched release sheet keyed to the lot code on that vial, with an HPLC main-peak purity result against a ≥99% internal target and a mass-spec identity confirmation. Verify the paperwork on each unit rather than assuming a shared document.
- Is the BPC-157 / TB-500 stack approved for human use?
- No. Neither BPC-157 nor TB-500 is approved for human use. Titan supplies both strictly as research-use-only compounds for in-vitro laboratory work — not for human or animal consumption, and not for diagnostic, therapeutic, or preventative use.